$50.00
Thymosin B4 Acetate
Contents: 5mg of Thymosin B4 Acetate
Form: Lyophilized Powder
Purity: ≥ 99% USA Tested, Verified Purity (HPLC Tested)
Verification: Verifiable COA’s (Batch-Matched)
Emerging Research Evidence:
TB-500 5mg is studied in laboratory models to investigate the pathways of structural resilience and mobile signaling. This synthetic peptide allows researchers to observe how cells coordinate actin-binding behavior and maintain framework integrity within a controlled environment. The focus remains on gathering data regarding cellular organization and signal coordination, providing a technical framework for understanding how internal pathways support biological agility and systemic balance at a molecular level.
Keep research materials in cool, dark, dry place.
Sold for Research Use Only / Not FDA Regulated
Batch-verified inventory. See COA.
In stock
TB-500 5mg is a synthetic peptide fragment utilized in laboratory models to study structural resilience and mobile signaling. This analog, modeled after naturally occurring proteins, is researched for its role in coordinating actin filament dynamics and maintaining the integrity of the cellular framework. Researchers use this 5mg tool to observe how molecules support cytoskeletal organization within a controlled environment.
Investigators employ TB-500 to analyze the timing of intracellular communication and how peptide-receptor interactions influence biological agility at a molecular level. By mapping these signaling cascades, researchers gather technical data on how cells maintain internal coordination and pathway persistence.
Current studies focus on exploring the mechanisms of signal modulation and structural behavior. This 5mg vial provides a precise technical framework for investigating the resilient signaling networks that support system integrity, without focusing on clinical recovery or therapeutic results.
CAS Number: 885340-08-9
Molecular Formula: C₃₈H₆₅N₁₁O₁₄
Molecular Weight: ~889.0 g/mol
Monoisotopic Mass: ~888.4916 Da
Parent Compound:
Thymosin β4 (Tβ4), a naturally occurring actin-binding protein; TB-500 represents a synthetic fragment used for research purposes.
TB-500 is utilized in pre-clinical research models across the following areas:
Actin & Cytoskeletal Dynamics
Investigating peptide-mediated regulation of actin binding and intracellular structural organization.
Cellular Signaling Coordination
Studying how cytoskeletal signaling pathways interact with broader intracellular communication networks.
Peptide–Protein Interaction Studies
Examining binding behavior, signaling specificity, and pathway modulation at the molecular level.
Structural Pathway Mapping
Researching how peptide fragments influence cytoskeletal architecture and signal transmission.
Cellular Stress-Response Signaling Models
Evaluating signaling adaptations within cells exposed to controlled experimental stressors, without physiological or therapeutic interpretation.
TB-500 is a specialized research analyte used to explore the pathways of structural mobility and framework resilience. In laboratory settings, this peptide allows researchers to observe how cells coordinate actin-associated signaling and maintain cytoskeletal dynamics within a controlled environment. These exploratory studies focus on mapping the timing of cellular organization signals and how molecular interactions support biological agility, providing technical data on signaling behavior without any focus on therapeutic or recovery outcomes.
TB-500 is intended for laboratory research use only. Not for human or veterinary consumption. Not approved by the FDA for therapeutic or diagnostic use. All referenced studies are pre-clinical and exploratory.
For Research Use Only — Not for Human or Veterinary Use. Not evaluated or approved by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. All information on this website is provided strictly for laboratory research and educational purposes. Nothing herein constitutes medical, clinical, or legal advice, nor an endorsement of non-laboratory use. Any discussion of specific peptides or potential research findings is informational only and must not be interpreted as guidance for use in or on humans or animals.
